Crescent Biopharma, Inc.
NASDAQCrescent Biopharma reports today with short sellers holding their largest position in weeks — a clear signal that the bear camp sees the earnings release as a test rather than a rubber stamp. Short interest has climbed sharply. It now accounts for roughly 33.5% of the free float, up from around 28% just three sessions ago. That 19% week-on-week rise makes CBIO one of the more…
CBIO short interest utilization surges to 93.31%, near its 52-week peak of 99.42%, as shares available to borrow tighten sharply.
Snapshot as of 2 Jun 2026
Crescent Biopharma reports today with short sellers holding their largest position in weeks — a clear signal that the bear camp sees the earnings release as a test rather than a rubber stamp. Short interest has climbed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CBIO — free to start on ORTEX.
Sign up for free →Open CBIO on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CBIO data →